Determination of Rosuvastatin and its Metabolite N-Desmethyl Rosuvastatin in Human Plasma by Liquid Chromatography–High Resolution Mass Spectrometry: Method Development, Validation, and Application to Pharmacokinetic Study

References

• Olsson, A. G.; McTaggart, F.; Raza, A. Rosuvastatin: A Highly Effective New HMG-CoA Reductase Inhibitor. Cardiovasc. Drug Rev. 2002, 20 (4), 303–328.
   PubMed Web of Science ®Google Scholar
• Istvan, E. S.; Deisenhofer, J. Structural Mechanism for Statin Inhibition of HMG-CoA Reductase. Science 2001, 292 (5519), 1160–1164.
   PubMed Web of Science ®Google Scholar
• Wierzbicki, A. S.; Poston, R.; Ferro, A. The Lipid and Non-lipid Effects of Statins. Pharmacol. Ther. 2003, 99 (1), 95–112.
   PubMed Web of Science ®Google Scholar
• Davidson, M. H. Rosuvastatin: A Highly Efficacious Statin for the Treatment of Dyslipidaemia. Expert Opin. Inv. Drug. 2002, 11 (1), 125–141.
   Web of Science ®Google Scholar
• McTaggart, F.; Jones, P. Effects of Statins on High-density Lipoproteins: A Potential Contribution to Cardiovascular Benefit. Cardiovasc. Drug. Ther. 2008, 22 (4), 321–338.
   PubMed Web of Science ®Google Scholar
• Jones, P. H.; Davidson, M. H.; Stein, E. A.; Bays, H. E.; McKenney, J. M.; Miller, E.; et al. Comparison of the Efficacy and Safety of Rosuvastatin Versus Atorvastatin, Simvastatin, and Pravastatin Across Doses (STELLAR* Trial). Am. J. Cardiol. 2003, 92 (2), 152–160.
   PubMed Web of Science ®Google Scholar
• McTaggart, F. Comparative Pharmacology of Rosuvastatin. Atherosclerosis Supp. 2003, 4 (1), 9–14.
   PubMed Web of Science ®Google Scholar
• Jones, P.; Davidson, M.; Stein, E.; Bays, H.; McKenney, J.; Miller, E.; et al. Comparison of the Efficacy and Safety of Rosuvastatin Versus Atorvastatin, Simvastatin, and Pravastatin Across Doses (STELLAR* Trial). Am. J. Cardiol. 2003, 92, 152–160.
   PubMed Web of Science ®Google Scholar
• Martin, P. D.; Mitchell, P. D.; Schneck, D. W. Pharmacodynamic Effects and Pharmacokinetics of a New HMG‐CoA Reductase Inhibitor, Rosuvastatin, After Morning or Evening Administration in Healthy Volunteers. Brit. J. Clin. Pharmacol. 2002, 54 (5), 472–477.
   PubMed Web of Science ®Google Scholar
• Lee, E.; Ryan, S.; Birmingham, B.; Zalikowski, J.; March, R.; Ambrose, H.; et al. Rosuvastatin Pharmacokinetics and Pharmacogenetics in White and Asian Subjects Residing in the Same Environment. Clin. Pharmacol. Ther. 2005, 78 (4), 330–341.
   PubMed Web of Science ®Google Scholar
• Li, Y.; Jiang, X.; Lan, K.; Zhang, R.; Li, X.; Jiang, Q. Pharmacokinetic Properties of Rosuvastatin After Single-dose, Oral Administration in Chinese Volunteers: A Randomized, Open-label, Three-way Crossover Study. Clin. Ther. 2007, 29 (10), 2194–2203.
   PubMed Web of Science ®Google Scholar
• Martin, P. D.; Warwick, M. J.; Dane, A. L.; Brindley, C.; Short, T. Absolute Oral Bioavailability of Rosuvastatin in Healthy White Adult Male Volunteers. Clin. Ther. 2003, 25 (10), 2553–2563.
   PubMed Web of Science ®Google Scholar
• White, C. M. A Review of the Pharmacologic and Pharmacokinetic Aspects of Rosuvastatin. J. Clin. Pharmacol. 2002, 42 (9), 963–970.
   PubMed Web of Science ®Google Scholar
• Martin, P. D.; Warwick, M. J.; Dane, A. L.; Cantarini, M. V. A Double-blind, Randomized, Incomplete Crossover Trial to Assess the Dose Proportionality of Rosuvastatin in Healthy Volunteers. Clin. Ther. 2003, 25 (8), 2215–2224.
   PubMed Web of Science ®Google Scholar
• Martin, P. D.; Warwick, M. J.; Dane, A. L.; Hill, S. J.; Giles, P. B.; Phillips, P. J.; et al. Metabolism, Excretion, and Pharmacokinetics of Rosuvastatin in Healthy Adult Male Volunteers. Clin. Ther. 2003, 25 (11), 2822–2835.
   PubMed Web of Science ®Google Scholar
• Gomes, F. P.; García, P. L.; Porto Alves, J. M.; Singh, A. K.; Kedor-Hackmann, E. R. M.; Miritello Santoro, M. I. R. Development and Validation of Stability-Indicating HPLC Methods for Quantitative Determination of Pravastatin, Fluvastatin, Atorvastatin, and Rosuvastatin in Pharmaceuticals. Anal. Lett. 2009, 42 (12), 1784–1804.
   Web of Science ®Google Scholar
• Kumar, T. R.; Shitut, N. R.; Kumar, P. K.; Vinu, M. C. A.; Kumar, V. V. P.; Mullangi, R.; et al. Determination of Rosuvastatin in Rat Plasma by HPLC: Validation and Its Application to Pharmacokinetic Studies. Biomed. Chromatogr. 2006, 20 (9), 881–887.
   PubMed Web of Science ®Google Scholar
• Vittal, S.; Shitut, N. R.; Kumar, T. R.; Vinu, M. C. A.; Mullangi, R.; Srinivas, N. R. Simultaneous Quantitation of Rosuvastatin and Gemfibrozil in Human Plasma by High-performance Liquid Chromatography and Its Application to a Pharmacokinetic Study. Biomed. Chromatogr. 2006, 20 (11), 1252–1259.
   PubMed Web of Science ®Google Scholar
• Shah, Y.; Iqbal, Z.; Ahmad, L.; Khan, A.; Khan, M. I.; Nazir, S.; et al. Simultaneous Determination of Rosuvastatin and Atorvastatin in Human Serum Using RP-HPLC/UV Detection: Method Development, Validation and Optimization of Various Experimental Parameters. J. Chromatogr B. 2011, 879 (9), 557–563.
   PubMed Web of Science ®Google Scholar
• Hull, C. K.; Penman, A. D.; Smith, C. K.; Martin, P. D. Quantification of Rosuvastatin in Human Plasma by Automated Solid-phase Extraction Using Tandem Mass Spectrometric Detection. J. Chromatogr B. 2002, 772 (2), 219–228.
   PubMed Web of Science ®Google Scholar
• Singh, S. S.; Sharma, K.; Patel, H.; Jain, M.; Shah, H.; Gupta, S.; et al. Estimation of Rosuvastatin in Human Plasma by HLPC Tandem Mass Spectroscopic Method and Its Application to Bioequivalence Study. Journal of Brazilian Chemical Society 2005, 16 (5), 944–950.
   Web of Science ®Google Scholar
• Oudhoff, K. A.; Sangster, T.; Thomas, E.; Wilson, I. D. Application of Microbore HPLC in Combination with Tandem MS for the Quantification of Rosuvastatin in Human Plasma. J. Chromatogr. B. 2006, 832 (2), 191–196.
   PubMed Web of Science ®Google Scholar
• Xu, D.-H.; Ruan, Z.-R.; Zhou, Q.; Yuan, H.; Jiang, B. Quantitative Determination of Rosuvastatin in Human Plasma by Liquid Chromatography with Electrospray Ionization Tandem Mass Spectrometry. Rapid Commun. Mass Spectrom. 2006, 20 (16), 2369–2375.
   PubMed Web of Science ®Google Scholar
• Lan, K.; Jiang, X.; Li, Y.; Wang, L.; Zhou, J.; Jiang, Q.; et al. Quantitative Determination of Rosuvastatin in Human Plasma by Ion Pair Liquid-liquid Extraction Using Liquid Chromatography with Electrospray Ionization Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2007, 44 (2), 540–546.
   PubMed Web of Science ®Google Scholar
• Gao, J.; Zhong, D.; Duan, X.; Chen, X. Liquid Chromatography/negative Ion Electrospray Tandem Mass Spectrometry Method for the Quantification of Rosuvastatin in Human Plasma: Application to a Pharmacokinetic Study. J. Chromatogr. B. 2007, 856 (1–2), 35–40.
   PubMed Web of Science ®Google Scholar
• Trivedi, R. K.; Kallem, R. R.; Mullangi, R.; Srinivas, N. R. Simultaneous Determination of Rosuvastatin and Fenofibric Acid in Human Plasma by LC-MS/MS with Electrospray Ionization: Assay Development, Validation and Application to a Clinical Study. J. Pharm. Biomed. Anal. 2005, 39 (3–4), 661–669.
   PubMed Web of Science ®Google Scholar
• Hull, C. K.; Martin, P. D.; Warwick, M. J.; Thomas, E. Quantification of the N-desmethyl Metabolite of Rosuvastatin in Human Plasma by Automated SPE Followed by HPLC with Tandem MS Detection. J. Pharm. Biomed. Anal. 2004, 35 (3), 609–614.
   PubMed Web of Science ®Google Scholar
• Lee, H.; Ho, C.; Hu, M.; Tomlinson, B.; Wong, C. Development and Validation of a Sensitive Method for Simultaneous Determination of Rosuvastatin and N‐desmethyl Rosuvastatin in Human Plasma Using Liquid Chromatography/negative Electrospray Ionization/tandem Mass Spectrometry. Biomed. Chromatogr. 2013, 27 (11), 1369–1374.
   PubMed Web of Science ®Google Scholar
• Macwan, J. S.; Ionita, I. A.; Akhlaghi, F. A Simple Assay for the Simultaneous Determination of Rosuvastatin Acid, Rosuvastatin-5S-lactone, and N-desmethyl Rosuvastatin in Human Plasma Using Liquid Chromatography–tandem Mass Spectrometry (LC-MS/MS). Anal. Bioanal. Chem. 2012, 402 (3), 1–11.
   PubMed Web of Science ®Google Scholar
• Épshtein, N. A. Validation of HPLC Techniques for Pharmaceutical Analysis. Pharm. Chem. J. 2004, 38 (4), 212–228.
   Google Scholar
• Peters, F. T.; Drummer, O. H.; Musshoff, F. Validation of New Methods. Forensic Sci. Int. 2007, 165 (2), 216–224.
   PubMed Web of Science ®Google Scholar
• Olsson, A. G.; McTaggart, F.; Raza, A. Rosuvastatin: A Highly Effective New HMG‐CoA Reductase Inhibitor. Cardiovas. Drug Rev. 2002, 20 (4), 303–328.
   PubMed Web of Science ®Google Scholar
• Cooper, K. J.; Martin, P. D.; Dane, A. L.; Warwick, M. J.; Schneck, D. W.; Cantarini, M. V. Effect of Itraconazole on the Pharmacokinetics of Rosuvastatin. Clin. Pharmacol. Ther. 2003, 73 (4), 322–329.
   PubMed Web of Science ®Google Scholar
• Zhang, W.; Deng, S.; Chen, X. P.; Zhou, G.; Xie, H. T.; He, F. Y.; et al. Pharmacokinetics of Rosuvastatin when Coadministered with Rifampicin in Healthy Males: A Randomized, Single-blind, Placebo-controlled, Crossover Study. Clin. Ther. 2008, 30 (7), 1283–1289.
   PubMed Web of Science ®Google Scholar
• Kosoglou, T.; Statkevich, P.; Yang, B.; Suresh, R.; Zhu, Y.; Boutros, T.; et al. Pharmacodynamic Interaction between Ezetimibe and Rosuvastatin. Curr. Med. Res. Opin. 2004, 20 (8), 1185–1195.
   PubMed Web of Science ®Google Scholar
• Martin, P. D.; Dane, A. L.; Schneck, D. W.; Warwick, M. J. An Open-label, Randomized, Three-way Crossover Trial of the Effects of Coadministration of Rosuvastatin and Fenofibrate on the Pharmacokinetic Properties of Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers. Clin. Ther. 2003, 25 (2), 459–471.
   PubMed Web of Science ®Google Scholar
• Busti, A. J.; Bain, A. M.; Hall, R. G. I. I.; Bedimo, R. G.; Leff, R. D.; Meek, C.; et al. Effects of Atazanavir/ritonavir or Fosamprenavir/ritonavir on the Pharmacokinetics of Rosuvastatin. J. Cardiov. Pharmacol. 2008, 51 (6), 605.
   PubMed Web of Science ®Google Scholar
• Cooper, K.; Martin, P.; Dane, A.; Warwick, M.; Schneck, D.; Cantarini, M. The Effect of Fluconazole on the Pharmacokinetics of Rosuvastatin. Eur. J. Clin. Pharmacol. 2002, 58 (8), 527–531.
   PubMed Web of Science ®Google Scholar
• Bergman, E.; Matsson, E. M.; Hedeland, M.; Bondesson, U.; Knutson, L.; Lennernäs, H. Effect of a Single Gemfibrozil Dose on the Pharmacokinetics of Rosuvastatin in Bile and Plasma in Healthy Volunteers. J. Clin. Pharmacol. 2010, 50 (9), 1039–1049.
   PubMed Web of Science ®Google Scholar
• Deng, J. W.; Shon, J. H.; Shin, H. J.; Park, S. J.; Yeo, C. W.; Zhou, H. H.; et al. Effect of Silymarin Supplement on the Pharmacokinetics of Rosuvastatin. Pharmac. Res. 2008, 25 (8), 1807–1814.
   PubMed Web of Science ®Google Scholar
• Cooper, K.; Martin, P.; Dane, A.; Warwick, M.; Raza, A.; Schneck, D. The Effect of Erythromycin on the Pharmacokinetics of Rosuvastatin. Eur. J. Clin. Pharmacol. 2003, 59 (1), 51–56.
   PubMed Web of Science ®Google Scholar